Pro-Osteogenic Effect of the Nutraceutical BlastiMin Complex

Humans Female Bone Diseases, Metabolic / drug therapy Dietary Supplements Bone Density / drug effects Aged Osteogenesis / drug effects Osteoporosis / drug therapy Middle Aged Mesenchymal Stem Cells / metabolism Biomarkers Osteoblasts / metabolism Bone Remodeling / drug effects
BMD CRP CTX P1NP nutraceuticals osteoblasts osteoporosis

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
06 Aug 2024
Historique:
received: 19 07 2024
revised: 02 08 2024
accepted: 03 08 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 29 8 2024
Statut: epublish

Résumé

Osteoporosis is a chronic disease that affects millions of patients worldwide and is characterized by low bone mineral density (BMD) and increased risk of fractures. Notably, natural molecules can increase BMD and exert pro-osteogenic effects. Noteworthily, the nutraceutical BlastiMin Complex

Identifiants

DOI: 10.3390/ijms25168565 PMID: 39201253
pubmed: 39201253
pii: ijms25168565
doi: 10.3390/ijms25168565
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Clinical Trial

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : European Union-POR MARCHE FESR 2014/2020
ID : I34I19007170007

Auteurs

Sofia Sabatelli (S)

Clinic of Endocrinology and Metabolic Diseases, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, 60126 Ancona, Italy.

Emanuele-Salvatore Scarpa (ES)

R&D Department, Mivell S.r.l.s., 61032 Fano, Italy.
ORCID: 0000-0001-8675-0790

Angelica Giuliani (A)

Department of Clinical and Molecular Sciences (DISCLIMO), Università Politecnica delle Marche, 60126 Ancona, Italy.
ORCID: 0000-0002-8477-8519

Chiara Giordani (C)

Clinic of Laboratory and Precision Medicine, IRCCS Istituto Nazionale di Ricovero e Cura per Anziani (INRCA), 60126 Ancona, Italy.
ORCID: 0000-0003-1733-654X

Jacopo Sabbatinelli (J)

Department of Clinical and Molecular Sciences (DISCLIMO), Università Politecnica delle Marche, 60126 Ancona, Italy.
Clinic of Laboratory and Precision Medicine, IRCCS Istituto Nazionale di Ricovero e Cura per Anziani (INRCA), 60126 Ancona, Italy.
ORCID: 0000-0001-9947-6778

Maria Rita Rippo (MR)

Department of Clinical and Molecular Sciences (DISCLIMO), Università Politecnica delle Marche, 60126 Ancona, Italy.
ORCID: 0000-0003-3024-3495

Sara Cabodi (S)

R&D Department, Diatech Pharmacogenetics S.r.l., 60035 Jesi, Italy.

Barbara Petrini (B)

R&D Department, Diatech Pharmacogenetics S.r.l., 60035 Jesi, Italy.

Giancarlo Balercia (G)

Division of Endocrinology, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, 60126 Ancona, Italy.

Gilberta Giacchetti (G)

Clinic of Endocrinology and Metabolic Diseases, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, 60126 Ancona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Pro-Osteogenic Effect of the Nutraceutical...
questionsmedicales.fr › Maladies métaboliques et nutritionnelles › Maladies métaboliques › Maladies osseuses métaboliques › Pro-Osteogenic Effect of the Nutraceutical...
questionsmedicales.fr › Aliments et boissons › Aliments › Compléments alimentaires › Pro-Osteogenic Effect of the Nutraceutical...
questionsmedicales.fr › Phénomènes physiologiques de l'appareil locomoteur et du système nerveux › Phénomènes physiologiques du système locomoteur › Densité osseuse › Pro-Osteogenic Effect of the Nutraceutical...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Pro-Osteogenic Effect of the Nutraceutical...
questionsmedicales.fr › Phénomènes physiologiques de l'appareil locomoteur et du système nerveux › Phénomènes physiologiques du système locomoteur › Développement locomoteur › Biominéralisation › Développement osseux › Ostéogenèse › Pro-Osteogenic Effect of the Nutraceutical...
questionsmedicales.fr › Maladies métaboliques et nutritionnelles › Maladies métaboliques › Maladies osseuses métaboliques › Ostéoporose › Pro-Osteogenic Effect of the Nutraceutical...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Pro-Osteogenic Effect of the Nutraceutical...
questionsmedicales.fr › Cellules › Cellules souches › Cellules souches multipotentes › Cellules souches mésenchymateuses › Pro-Osteogenic Effect of the Nutraceutical...
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Pro-Osteogenic Effect of the Nutraceutical...
questionsmedicales.fr › Cellules › Cellules du tissu conjonctif › Ostéoblastes › Pro-Osteogenic Effect of the Nutraceutical...
questionsmedicales.fr › Phénomènes biologiques › Régénération › Remodelage osseux › Pro-Osteogenic Effect of the Nutraceutical...